# Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

> **NCT02582034** · PHASE2 · COMPLETED · sponsor: **Center Eugene Marquis** · enrollment: 56 (actual)

## Conditions studied

- Adenoma, Liver Cell

## Interventions

- **RADIATION:** Optimized Internal Radiation Therapy
- **RADIATION:** Standard Internal Radiation Therapy

## Key facts

- **NCT ID:** NCT02582034
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582034, "Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02582034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*